3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | |
| | (単位:千円) |
| 前連結会計年度 (2020年3月31日) | 当連結会計年度 (2021年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 5,249,810 | 7,230,744 |
受取手形及び売掛金 | 2,604,688 | 2,954,087 |
有価証券 | - | 55,765 |
たな卸資産 | 4,031,729 | 4,071,369 |
その他 | 593,842 | 470,119 |
貸倒引当金 | △70,170 | △2,056 |
流動資産合計 | 12,409,899 | 14,780,029 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 18,773,727 | 19,112,933 |
減価償却累計額 | △11,032,862 | △11,546,772 |
建物及び構築物(純額) | 7,740,864 | 7,566,161 |
機械装置及び運搬具 | 1,963,854 | 1,993,760 |
減価償却累計額 | △1,228,611 | △1,281,015 |
機械装置及び運搬具(純額) | 735,243 | 712,744 |
工具、器具及び備品 | 6,341,356 | 6,443,694 |
減価償却累計額 | △5,535,878 | △5,678,950 |
工具、器具及び備品(純額) | 805,478 | 764,744 |
土地 | 2,793,704 | 2,803,260 |
リース資産 | 1,359,673 | 1,205,578 |
減価償却累計額 | △590,365 | △611,165 |
リース資産(純額) | 769,307 | 594,412 |
建設仮勘定 | 855,136 | 456,647 |
有形固定資産合計 | 13,699,735 | 12,897,971 |
無形固定資産 | 194,361 | 213,762 |
投資その他の資産 | | |
投資有価証券 | 12,008,319 | 8,286,937 |
長期貸付金 | 455,303 | 37,523 |
繰延税金資産 | 1,829 | 521,612 |
その他 | 234,912 | 234,567 |
貸倒引当金 | △2,066 | - |
投資その他の資産合計 | 12,698,297 | 9,080,641 |
固定資産合計 | 26,592,394 | 22,192,374 |
資産合計 | 39,002,293 | 36,972,404 |
| | |
| | (単位:千円) |
| 前連結会計年度 (2020年3月31日) | 当連結会計年度 (2021年3月31日) |
負債の部 | | |
流動負債 | | |
買掛金 | 119,257 | 95,012 |
短期借入金 | 5,998,285 | 3,486,826 |
未払法人税等 | 502,271 | 683,229 |
前受金 | 4,282,679 | 5,317,925 |
事業整理損失引当金 | 15,521 | 15,419 |
その他 | 2,033,146 | 2,317,390 |
流動負債合計 | 12,951,162 | 11,915,803 |
固定負債 | | |
長期借入金 | 8,217,304 | 8,669,916 |
リース債務 | 707,466 | 529,324 |
繰延税金負債 | 726,098 | - |
その他 | 18,414 | 18,573 |
固定負債合計 | 9,669,283 | 9,217,814 |
負債合計 | 22,620,445 | 21,133,617 |
純資産の部 | | |
株主資本 | | |
資本金 | 9,679,070 | 9,679,070 |
資本剰余金 | 5,196,804 | 2,306,771 |
利益剰余金 | △2,489,003 | 3,854,474 |
自己株式 | △197 | △197 |
株主資本合計 | 12,386,673 | 15,840,118 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 6,094,751 | 2,096,313 |
為替換算調整勘定 | △2,193,352 | △2,201,981 |
その他の包括利益累計額合計 | 3,901,398 | △105,667 |
非支配株主持分 | 93,775 | 104,335 |
純資産合計 | 16,381,848 | 15,838,786 |
負債純資産合計 | 39,002,293 | 36,972,404 |
E0538523950株式会社新日本科学Shin Nippon Biomedical Laboratories, Ltd通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2020-04-012021-03-31FY2021-03-312019-04-012020-03-312020-03-311falsefalsefalse239502019-04-012020-03-31jppfs_cor:CapitalStockMember239502019-04-012020-03-31jppfs_cor:CapitalSurplusMember239502020-03-31jppfs_cor:CapitalSurplusMember239502020-03-31jppfs_cor:RetainedEarningsMember239502020-03-31jppfs_cor:TreasuryStockMember239502020-03-31jppfs_cor:ShareholdersEquityMember239502020-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember239502020-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember239502020-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember239502020-03-31jppfs_cor:NonControllingInterestsMember239502019-04-012020-03-31jppfs_cor:TreasuryStockMember239502019-03-31jppfs_cor:CapitalStockMember239502019-03-31jppfs_cor:CapitalSurplusMember239502021-03-31jppfs_cor:ShareholdersEquityMember239502021-03-31jppfs_cor:CapitalStockMember239502021-03-31jppfs_cor:CapitalSurplusMember239502021-03-31jppfs_cor:RetainedEarningsMember239502021-03-31jppfs_cor:TreasuryStockMember239502021-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember239502021-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember239502020-04-012021-03-31jppfs_cor:RetainedEarningsMember239502020-04-012021-03-31jppfs_cor:TreasuryStockMember239502020-04-012021-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember239502020-04-012021-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember239502020-04-012021-03-31jppfs_cor:NonControllingInterestsMember239502019-03-31jppfs_cor:TreasuryStockMember239502019-03-31jppfs_cor:ShareholdersEquityMember239502019-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember239502019-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember239502019-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember239502019-03-31jppfs_cor:NonControllingInterestsMember239502019-04-012020-03-31jppfs_cor:RetainedEarningsMember239502019-04-012020-03-31jppfs_cor:ShareholdersEquityMember239502019-04-012020-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember239502019-04-012020-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember239502019-04-012020-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember239502020-03-31jppfs_cor:CapitalStockMember239502019-03-31jppfs_cor:RetainedEarningsMember239502020-04-012021-03-31jppfs_cor:ShareholdersEquityMember239502021-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember239502021-03-31jppfs_cor:NonControllingInterestsMember239502020-04-012021-03-31jppfs_cor:CapitalStockMember239502020-04-012021-03-31jppfs_cor:CapitalSurplusMember239502020-04-012021-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember239502019-04-012020-03-31jppfs_cor:NonControllingInterestsMember239502021-05-10239502021-03-31239502020-04-012021-03-31239502020-03-31239502019-04-012020-03-31239502019-03-31xbrli:pureiso4217:JPY